Editas Medicine, Inc. (NASDAQ:EDIT) Receives Consensus Recommendation of "Hold" from Analysts
MarketBeat
Shares of Editas Medicine, Inc. (NASDAQ:EDIT - Get Free Report) have been assigned a consensus rating of "Hold" from the thirteen research firms that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating, t
NASDAQ:EDIT